The Food and Drug Administration oversees a broad range of medical and consumer products. In fact, the agency estimates that up to a quarter of all U.S. consumer spending is on FDA-regulated items. The Pew Charitable Trusts understands the tremendous impact these products have on public health. This project complements our work supporting drug safety and effective and efficient regulation of medical devices by focusing attention on over-the-counter drugs and dietary supplements, as well as fields such as regenerative medicine, in order to safeguard consumers and patients.
Our WorkView All
The Pew Charitable Trusts, the American Academy of Pediatrics, March of Dimes, National Association of County and City Health Officials, and the Society for Maternal-Fetal Medicine thanked the House Energy and Commerce Subcommittee on Health in a Jan. 16 letter for advancing a bill that would reform regulation of over-the-counter (OTC) drugs. Read More
The Pew Charitable Trusts submitted comments to the Food and Drug Administration on Dec. 4 regarding the agency’s plan to create a list of dietary supplement ingredients that were on the market before passage of the Dietary Supplement Health and Education Act of 1994. Products containing ingredients that predate the legislation can be marketed without prior notice to FDA. Read More
Many service members take dietary supplements to enhance performance, build muscle, lose weight, or promote general well-being. Taking one or more of these products may be beneficial when a person does not get the recommended amount of nutrients from foods. Unfortunately, some supplements can cause serious injury or death. Dangerous supplements compromise the readiness of our armed forces and the... Read More